Taiwan News - 3 天前查看原文
Gene Solutions Leads the Way in Cancer Early Detection with Asia's First Clinical Validated Multi-Cancer Blood Test
SPOT-MAS aims to improve this by providing a reliable, non-invasive, multi-cancer blood test. The test incorporates next-generation sequencing (NGS) and artificial intelligence technologies to detect circulating tumor DNA (ctDNA) released from cancer cells into the bloodstream.